Charles Schwab Investment Management Inc Repligen Corp Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 357,901 shares of RGEN stock, worth $51.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

357,901

Previous 352,211 1.62%

Holding current value

$51.5 Million

Previous $64.8 Million 30.35%

% of portfolio

0.01%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$120.0 - $182.95 $682,800 - $1.04 Million	5,690 Added 1.62%	357,901 $45.1 Million
Q1 2024 May 08, 2024	BUY	$170.78 - $208.42 $1.67 Million - $2.03 Million	9,759 Added 2.85%	352,211 $64.8 Million
Q4 2023 Feb 06, 2024	BUY	$114.17 - $185.35 $1.8 Million - $2.93 Million	15,785 Added 4.83%	342,452 $61.6 Million
Q3 2023 Nov 08, 2023	BUY	$138.78 - $176.51 $1.2 Million - $1.53 Million	8,667 Added 2.73%	326,667 $51.9 Million
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $794,807 - $1.04 Million	5,742 Added 1.84%	318,000 $45 Million
Q1 2023 May 11, 2023	BUY	$154.26 - $198.1 $771,300 - $990,500	5,000 Added 1.63%	312,258 $52.6 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $2.01 Million - $2.73 Million	12,365 Added 4.19%	307,258 $52 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $165,232 - $263,896	1,030 Added 0.35%	294,893 $55.2 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $798,781 - $1.07 Million	5,678 Added 1.97%	293,863 $47.7 Million
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $1.13 Million - $1.8 Million	6,992 Added 2.49%	288,185 $54.2 Million
Q4 2021 Feb 11, 2022	BUY	$247.59 - $304.47 $1.84 Million - $2.26 Million	7,421 Added 2.71%	281,193 $74.5 Million
Q3 2021 Nov 16, 2021	SELL	$194.77 - $324.21 $21.4 Million - $35.6 Million	-109,949 Reduced 28.65%	273,772 $79.1 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $1.53 Million - $2.04 Million	9,244 Added 2.47%	383,721 $76.6 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $2.08 Million - $2.61 Million	-11,544 Reduced 2.99%	374,477 $72.8 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $343,841 - $479,655	-2,322 Reduced 0.6%	386,021 $74 Million
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $1.57 Million - $2.03 Million	12,830 Added 3.42%	388,343 $57.3 Million
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $8.06 Million - $12 Million	-85,392 Reduced 18.53%	375,513 $46.4 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $1.76 Million - $2.26 Million	20,664 Added 4.69%	460,905 $44.5 Million
Q4 2019 Feb 07, 2020	BUY	$73.84 - $93.08 $564,506 - $711,596	7,645 Added 1.77%	440,241 $40.7 Million
Q3 2019 Nov 08, 2019	BUY	$76.65 - $95.51 $10.3 Million - $12.8 Million	134,383 Added 45.06%	432,596 $33.2 Million
Q2 2019 Aug 09, 2019	SELL	$54.2 - $85.95 $319,238 - $506,245	-5,890 Reduced 1.94%	298,213 $25.6 Million
Q1 2019 May 14, 2019	BUY	$49.45 - $62.8 $1.85 Million - $2.35 Million	37,458 Added 14.05%	304,103 $18 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $2.54 Million - $3.62 Million	52,626 Added 24.59%	266,645 $14.1 Million
Q3 2018 Nov 13, 2018	BUY	$46.8 - $58.97 $553,082 - $696,907	11,818 Added 5.84%	214,019 $11.9 Million
Q2 2018 Aug 08, 2018	BUY	$35.26 - $47.04 $415,503 - $554,319	11,784 Added 6.19%	202,201 $9.51 Million
Q1 2018 May 07, 2018	SELL	$30.92 - $37.27 $605,506 - $729,858	-19,583 Reduced 9.33%	190,417 $6.89 Million
Q4 2017 Jan 17, 2018	SELL	$32.53 - $38.92 $468,041 - $559,980	-14,388 Reduced 6.41%	210,000 $7.62 Million
Q3 2017 Nov 13, 2017	BUY	$36.98 - $46.06 $8.3 Million - $10.3 Million	224,388	224,388 $8.6 Million

Others Institutions Holding RGEN

# of Institutions

497

Shares Held

53.9M

Call Options Held

423K

Put Options Held

85.3K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.98B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Repligen Corp Transaction History